Moxiclav Dosage/Direction for Use

Adults and children over 14 years: Mild - Moderate infections: MOXICLAV 375 mg tablet three times a day or one MOXICLAV 625 mg tablet two times a day.
Severe infections: MOXICLAV 625 mg tablet three times a day or one MOXICLAV 1 g tablet twice daily.
Children: Children 7-14 years: 10 ml MOXICLAV suspension three times a day or 5 ml MOXICLAV Forte suspension three times a day.
Children 2-7 years: 5 ml MOXICLAV suspension three times a day.
Children 9 months-2 years: 2.5 ml of MOXICLAV oral suspension (125 mg/5 ml) every 8 hours. In children less than 2 years old the daily administered dose of clavulanic acid should not be greater than 5 mg/kg of body weight. In case of severe infections dosage should not be increased.
Treatment with MOXICLAV should not be extended beyond 14 days unless otherwise advised by physician.
Dosage in Renal Impairment: Adults: Mild impairment (Creatinine clearance >30 ml/min): No changes in dosage.
Moderate impairment (Creatinine clearance 10-30 ml/min): one 375 mg tablet or one 625 mg tablet 12 hourly. Severe impairment (Creatinine clearance < 10ml/min): not more than one 375 mg tablet every 12 hours.
Children: For children with a Creatinine clearance >30 ml/min no adjustment in dosage in required.
For children with Creatinine clearance <30ml/min MOXICLAV Dry Powder for oral suspension and MOXICLAV Forte Dry Powder for oral suspension are not recommended.
Dosage in hepatic impairment: Dose with caution; monitor hepatic function at regular intervals.
Preparation and administration: Tablets should be swallowed whole without chewing. If required, tablets may be broken in half and swallowed without chewing.
To minimize potential gastrointestinal intolerance, administer at the start of a meal. The absorption of MOXICLAV is optimized when taken at start of a meal.